Life sciences news
-
VIB research at the basis of experimental gene therapy against dementia
Wednesday December 22nd 2021
Read more
-
Biotalys and Biobest enter into strategic partnership to expand reach of novel biocontrol solutions
Monday December 20th 2021
Read more
-
argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
Monday December 20th 2021
Read more
-
UCB announces positive Phase 3 results for rozanolixizumab in generalized myasthenia gravis
Friday December 10th 2021
Read more
-
Early detection of Omicron facilitated with Emweb's Genome Detective
Friday December 10th 2021
Read more
-
Biocartis’ Idylla™ SARS-CoV-2 testing successfully detects Omicron variant
Thursday December 9th 2021
Read more
-
MRM Health announces first patient dosed with next generation live microbiome consortia therapeutic MH002 in Phase 1b/2a study in patients with Ulcerative Colitis
Wednesday December 8th 2021
Read more
-
Spectacular results with Japanese encephalitis vaccine of ViroVet
Wednesday December 8th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Sequana Medical announces the completion of patient enrolment in POSEIDON, the North American pivotal alfapump® study
Tuesday December 7th 2021
Read more
-
Sequana Medical announces positive interim results of SAHARA DESERT, the alfapump DSR® study in heart failure patients with persistent congestion
Tuesday December 7th 2021
Read more
-
New start-up Trince raises EUR 4 million for innovative technology to produce personalized cancer therapies safer, cheaper, and faster
Monday December 6th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
